Antabio
Phase 1Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.
Founded
2007
Focus
Small Molecules
About
Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.
Funding History
2Total raised: $40M
Series B$25MAndera PartnersSep 15, 2021
Series A$15MKurma PartnersMay 15, 2019
Company Info
TypePrivate
Founded2007
LocationLabège, France
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile